Global Ceftriaxone Sodium Market Research Report 2021

Ceftriaxone sodium is a cephalosporin antibiotic.
There are three kinds of Ceftriaxone Sodium, which are ChP, USP and EP. ChP hold the largest share of the Ceftriaxone Sodium market, with a sales market share nearly 74% in 2019.
Ceftriaxone Sodium is used in Single Injection and Compound Injection. The most proportion of Ceftriaxone Sodium is used in Single Injection, and the market share in 2019 is about 96%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 12%.
For the production, China and India are the mainly manufactured base.
Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, etc. are the leader of the industry, and top 5 players hold about 50% revenue market share.

The global Ceftriaxone Sodium market was valued at US$ 284.4 million in 2019 and is expected to reach US$ 230.4 million by the end of 2026, growing at a CAGR of -2.7% during 2021-2026.
This report focuses on Ceftriaxone Sodium volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ceftriaxone Sodium market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Ceftriaxone Sodium Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
ChP
USP
EP

Segment by Application
Single Injection
Compound Injection

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Shandong Ruiying
Qilu Antibiotics
Nectar Lifesciences
Kelun
United Laboratories
Aurobindo Pharma
Orchid Pharma
Medya Pharma
REYOUNG
LKPC
ACS Dobfar
NCPC
Dawnrays
Kopran

Frequently Asked Questions